Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LQDA | LIQUIDIA CORP | $75.49 | $17.77 | 324.90% | 314.54x | 22.10x | 23.06x | 61.83x | 1.55x | $41.15M | 0.62% | $108.58M | 1.23 | $6.67B | 124.54 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $286.41 | $94.09 | 204.40% | 65.69x | 37.98x | 8.88x | 35.56x | 1.36x | $641.34M | 1.68% | $1.08B | 8.09 | $39.50B | 42.73 | ||
| CORT | CORCEPT THERAPEUTICS INC | $79.71 | $20.87 | 281.85% | 173.28x | 152.23x | 10.82x | 13.41x | 1.46x | $119.79M | 1.44% | $637.99M | 6.11 | $8.46B | -1,231.85 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $6.90 | $2.94 | 134.49% | 98.57x | 64.43x | 3.74x | 91.56x | 0.91x | $47.52M | 4.04% | $13.01M | 0.08 | $1.34B | 25.04 | ||
| HALO | HALOZYME THERAPEUTICS INC | $68.99 | $71.78 | -3.88% | 23.31x | 8.32x | 5.40x | 37.26x | 0.42x | $667.65M | 8.19% | $219.64M | 1.86 | $10.02B | 16.06 | ||
| KRYS | KRYSTAL BIOTECH INC | $343.43 | $95.97 | 257.87% | 44.31x | 43.19x | 24.10x | 7.93x | 2.12x | $237.38M | 2.36% | $1.28B | 43.59 | $9.63B | 45.02 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $57.13 | $17.43 | 227.82% | 58.30x | 44.75x | 5.80x | 7.26x | 1.58x | $164.23M | 3.76% | $605.69M | 7.92 | $4.21B | 37.80 | ||
| ADMA | ADMA BIOLOGICS INC | $8.57 | $9.75 | -12.08% | 12.42x | 9.37x | 3.97x | 5.09x | 0.48x | $107.90M | 5.33% | $390.33M | 1.65 | $2.05B | 9.24 | ||
| ASND | ASCENDIS PHARMA A | $228.00 | $81.19 | 180.83% | 24.17x | 15.29x | 13.90x | 24.67x | 2.47x | $52.94M | 0.37% | $574.09M | 9.24 | $14.54B | 155.94 | ||
| ZVRA | ZEVRA THERAPEUTICS INC | $12.65 | $16.06 | -21.25% | 6.17x | 26.39x | 6.04x | 3.63x | 0.82x | $56.42M | 7.64% | $205.80M | 3.52 | $653.36M | 4.52 | ||
| VCEL | VERICEL CORP | $40.47 | $9.19 | 340.27% | 94.12x | 83.95x | 7.03x | 5.80x | 1.98x | $47.49M | 2.31% | $356.23M | 7.02 | $2.05B | 50.77 | ||
| RPRX | ROYALTY PHARMA PLC | $53.57 | $40.13 | 33.50% | 28.05x | 10.04x | 9.59x | 3.10x | 0.60x | $2.34B | 10.00% | $9.94B | 22.75 | $39.22B | 33.71 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $55.90 | $42.04 | 32.98% | 39.93x | 14.74x | 3.32x | 1.74x | 0.55x | $767.06M | 7.13% | $6.21B | 32.27 | $9.16B | 18.99 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $225.92 | $49.70 | 354.54% | 480.68x | 8.78x | 3.15x | 3.13x | 1.62x | $1.30B | 9.28% | $4.53B | 73.22 | $17.73B | 26.27 | ||
| TGTX | TG THERAPEUTICS INC | $54.40 | $17.14 | 217.41% | 16.89x | 38.89x | 11.22x | 14.28x | 267.71x | -$14.19M | -0.18% | $583.13M | 4.04 | $8.64B | 57.57 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.21 | $5.77 | -61.70% | 8.19x | 3.23x | 2.07x | 2.42x | 0.17x | $7.24M | 5.70% | $52.93M | 0.92 | $74.31M | 4.80 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $33.43 | $35.96 | -7.05% | 13.21x | 9.09x | 2.15x | 2.13x | 0.50x | $341.79M | 17.68% | $910.35M | 15.75 | $1.50B | 6.35 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $262.17 | $94.96 | 176.08% | 33.19x | 28.89x | 18.99x | 5.27x | 1.67x | $122.22M | 2.34% | $997.32M | 50.16 | $5.59B | 24.79 | ||
| TECH | BIO-TECHNE CORP | $55.61 | $15.41 | 260.81% | 78.32x | 28.34x | 7.18x | 4.18x | 1.61x | $269.60M | 3.10% | $2.09B | 13.34 | $8.79B | 34.33 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $466.79 | $168.95 | 176.29% | 27.44x | 23.88x | 9.71x | 6.12x | 2.00x | $3.71B | 3.13% | $19.36B | 76.20 | $114.97B | 21.32 | ||
| EXEL | EXELIXIS INC | $51.35 | $31.03 | 65.47% | 16.46x | 15.59x | 5.58x | 6.67x | 1.20x | $917.69M | 6.92% | $1.94B | 7.49 | $12.85B | 12.17 | ||
| UTHR | UNITED THERAPEUTICS CORP | $538.30 | $244.72 | 119.97% | 18.38x | 18.92x | 7.39x | 3.87x | 2.03x | $1.02B | 4.34% | $5.90B | 135.66 | $21.57B | 12.59 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.41 | $2.47 | 37.81% | 14.21x | 14.41x | 2.09x | 3.30x | 0.96x | $4.11M | 1.50% | $82.33M | 1.03 | $207.61M | 9.77 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $612.50 | $438.64 | 39.64% | 14.39x | 13.02x | 4.27x | 2.04x | 0.97x | $4.11B | 6.46% | $31.42B | 302.15 | $63.96B | 11.13 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.38 | $12.32 | 154.67% | 17.34x | 16.00x | 6.43x | 3.79x | 3.89x | $208.13M | 5.42% | $1.01B | 8.28 | $3.09B | 9.22 | ||
| PLX | PROTALIX BIOTHERAPEUTICS INC | $2.16 | $1.27 | 70.37% | 11.37x | 9.94x | 2.26x | 2.59x | 2.80x | $13.00M | 7.55% | $67.23M | 0.84 | $140.80M | 6.31 | ||
| VCYT | VERACYTE INC | $53.19 | $7.65 | 595.63% | 47.92x | 47.70x | 7.81x | 3.16x | 10.21x | $155.34M | 3.67% | $1.34B | 16.90 | $4.02B | 34.93 | ||
| INCY | INCYTE CORP | $103.66 | $67.27 | 54.11% | 14.22x | 13.23x | 3.85x | 3.68x | 1.22x | $1.45B | 7.02% | $5.62B | 28.21 | $17.28B | 9.24 | ||
| MDXG | MIMEDX GROUP INC | $3.67 | $1.26 | 190.68% | 17.48x | -43.59x | 1.40x | 2.25x | 8.31x | $69.36M | 12.72% | $242.94M | 1.64 | $404.45M | 7.42 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $17.65 | $3.63 | 386.36% | 29.42x | 4.82x | 0.85x | 1.24x | 13.31x | $109.24M | 5.89% | $1.51B | 14.34 | $2.44B | 29.44 |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.